Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization. | PLoS One | 2022 | 36301939 | PubTator, text mining | PubMed |
| Subacute Pulmonary Toxicity of Glutaraldehyde Aerosols in a Human In Vitro Airway Tissue Model. | Int J Mol Sci | 2022 | 36292975 | PubTator, text mining | PubMed |
| Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma. | J Oncol | 2022 | 36284635 | PubTator, text mining | PubMed |
| Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4. | Front Mol Biosci | 2022 | 36275631 | PubTator, text mining | PubMed |
| Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. | Front Mol Biosci | 2022 | 36267158 | PubTator, text mining | PubMed |
| Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma. | Biomed Res Int | 2022 | 36246969 | PubTator, text mining | PubMed |
| A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening. | Front Genet | 2022 | 36246599 | PubTator, text mining | PubMed |
| Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration. | Front Oncol | 2022 | 36237322 | PubTator, text mining | PubMed |
| LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium. | Int J Mol Sci | 2022 | 36233185 | PubTator, text mining | PubMed |
| Gut microbiota-mitochondrial inter-talk in non-alcoholic fatty liver disease. | Front Nutr | 2022 | 36204383 | PubTator, text mining | PubMed |
| Novel NRF2-activated cancer treatments utilizing synthetic lethality. | IUBMB Life | 2022 | 36200139 | PubTator, text mining | PubMed |
| Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. | Medicine (Baltimore) | 2022 | 36197270 | PubTator, text mining | PubMed |
| Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma. | Front Immunol | 2022 | 36189258 | PubTator, text mining | PubMed |
| Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood. | Front Immunol | 2022 | 36189251 | PubTator, text mining | PubMed |
| A standardized nomenclature for mammalian histone genes. | Epigenetics Chromatin | 2022 | 36180920 | PubTator, text mining | PubMed |
| Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization. | Life (Basel) | 2022 | 36143474 | PubTator, text mining | PubMed |
| An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy. | Antioxidants (Basel) | 2022 | 36139836 | PubTator, text mining | PubMed |
| Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples. | JHEP Rep | 2022 | 36119721 | PubTator, text mining | PubMed |
| Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology. | Transl Oncol | 2022 | 36113344 | PubTator, text mining | PubMed |
| Novel Genomic Variants, Atypical Phenotypes and Evidence of a Digenic/Oligogenic Contribution to Disorders/Differences of Sex Development in a Large North African Cohort. | Front Genet | 2022 | 36110220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=19